||Drug - We have evaluated the clinical efficacy of a characterized PRP product prepared in a standardized manner and in a closed-system as knee osteoarthritis (KOA) treatment, and evaluated the association of the clinical response to PRP-related variables.
PRP was prepared from a donation of autologous blood, obtaining three aliquots of approximately 10 mL of product that were stored frozen until administration. Patients were treated three consecutive times every four weeks with an intraarticular PRP knee infiltration under sterile conditions.
|Number of sites
|Type of statistical analyses
||One-arm interventional pretest posttest study, monocentric and pragmatic
|Duration of trial
||Clinical results of this PRP treatment on symptomatic KOA